TWD 75.0
(-0.13%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Revenue | 5.76 Billion | 4.34 Billion | 2.79 Billion |
Cost of Revenue | 3.1 Billion | 2.37 Billion | 1.7 Billion |
Gross Profit | 2.65 Billion | 1.97 Billion | 1.08 Billion |
Operating Expenses | 2.14 Billion | 1.61 Billion | 1.14 Billion |
Selling, General and Administrative Expenses | 2.13 Billion | 1.6 Billion | 1.13 Billion |
Research and Development Expenses | 12.87 Million | 9.16 Million | 4.04 Million |
Other Expenses | 1.00 | 13.27 Million | 44.37 Million |
Cost and Expenses | 5.25 Billion | 3.98 Billion | 2.85 Billion |
Operating Income | 508.43 Million | 382.65 Million | -9.96 Million |
Interest Expense | 41.48 Million | 26.04 Million | 18.59 Million |
Income Tax Expense | 87.73 Million | 45.48 Million | 30.06 Million |
Earnings before Tax | 442.29 Million | 356.61 Million | -28.55 Million |
Net Income | 355 Million | 271.98 Million | -59.32 Million |
Earnings Per Share Basic | 8.61 | 8.74 | -2.51 |
Earnings Per Share Diluted | 8.60 | 8.74 | -2.51 |
Weighted Average Shares Outstanding | 41.25 Million | 31.12 Million | 23.65 Million |
Weighted Average Shares Outstanding (Diluted) | 41.25 Million | 31.12 Million | 23.65 Million |
Gross Margin | 0.46 | 0.45 | 0.39 |
EBIT Margin | 0.18 | 0.17 | 0.10 |
Profit Margin | 0.06 | 0.06 | -0.02 |
EBITDA | 1.03 Billion | 742.64 Million | 285.92 Million |
Earnings Before Tax Margin | 0.09 | 0.09 | -0.00 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 1.42 Billion | 1.42 Billion | 5.76 Billion | 1.47 Billion | 1.47 Billion | 1.4 Billion |
Cost of Revenue | 766.97 Million | 766.97 Million | 3.1 Billion | 803.74 Million | 803.74 Million | 750.96 Million |
Gross Profit | 662.17 Million | 662.17 Million | 2.65 Billion | 670.64 Million | 670.64 Million | 656.04 Million |
Operating Expenses | 582.86 Million | 581.19 Million | 2.14 Billion | 564.16 Million | 564.16 Million | 522.25 Million |
Selling, General and Administrative Expenses | 577.75 Million | 577.75 Million | - | 551.7 Million | 551.7 Million | 514.33 Million |
Research and Development Expenses | 5.11 Million | 5.11 Million | - | 4.15 Million | 4.15 Million | 2.28 Million |
Other Expenses | - | - | -27.87 Million | - | - | - |
Cost and Expenses | 1.34 Billion | 1.34 Billion | 5.25 Billion | 1.36 Billion | 1.36 Billion | 1.27 Billion |
Operating Income | 79.3 Million | 79.3 Million | 483.78 Million | 114.78 Million | 114.78 Million | 139.42 Million |
Interest Expense | - | - | 41.48 Million | - | - | - |
Income Tax Expense | 14.19 Million | 14.19 Million | 87.73 Million | 18.91 Million | 18.91 Million | 24.94 Million |
Earnings before Tax | 69.81 Million | 69.81 Million | 442.29 Million | 95.58 Million | 95.58 Million | 125.56 Million |
Net Income | 59.57 Million | 59.57 Million | 355 Million | 76.88 Million | 76.88 Million | 100.61 Million |
Earnings Per Share Basic | 1.30 | 1.30 | - | 1.80 | 1.80 | 2.53 |
Earnings Per Share Diluted | 1.30 | 1.30 | - | 1.80 | 1.80 | 2.52 |
Weighted Average Shares Outstanding | 45.84 Million | 45.82 Million | 31.12 Million | 42.72 Million | 42.72 Million | 39.84 Million |
Weighted Average Shares Outstanding (Diluted) | 45.87 Million | 45.82 Million | 31.12 Million | 42.66 Million | 42.66 Million | 39.85 Million |
Gross Margin | 0.46 | 0.46 | 0.46 | 0.45 | 0.45 | 0.47 |
EBIT Margin | 0.12 | 0.17 | - | 0.13 | 0.13 | 0.14 |
Profit Margin | 0.04 | 0.04 | 0.06 | 0.05 | 0.05 | 0.07 |
EBITDA | 164.81 Million | 246.76 Million | - | 187.97 Million | 187.97 Million | 203.51 Million |
Earnings Before Tax Margin | 0.06 | 0.06 | 0.08 | 0.08 | 0.08 | 0.10 |
BLES
CEREBRAINT
VRANDA
688772
5261
ANFGF